Protagonist Therapeutics, Inc.
Headquarters country
United States
Registry sponsor category
Industry
- Other names
- Protagonist Therapeutics, Inc.
- Company name
- Protagonist Therapeutics, Inc.
- Organisation type
- Industry
- Registered legal name
- Protagonist Therapeutics, Inc
- US industry code (SIC)
- Pharmaceutical preparations
- Registry sponsor category
- Industry
- SEC filer number (CIK)
- 0001377121
Related records
Trials (14)
- A Phase 3 Study of Rusfertide in Patients With Polycythemia Vera
- Hepcidin Mimetic in Patients With Polycythemia Vera (REVIVE)
- Pharmacokinetics and Pharmacodynamics of Different PTG-300 Regimens in Healthy Volunteers
- Pharmacokinetics of PN-232 in Healthy Volunteers
- Pharmacokinetics of PN-235 in Healthy Volunteers
- PN-943 in Adults With Moderate to Severe Active Ulcerative Colitis (UC)
- PTG-100 for Patients With Celiac Disease
- PTG-300 in Patients With Polycythemia Vera and Elevated Hematocrit
- PTG-300 in Subjects With Hereditary Hemochromatosis
- Safety and Efficacy Study of PTG-100 in the Treatment of Moderate to Severe Ulcerative Colitis
- Safety Study for Beta Thalassemia Subjects on PTG-300
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PN-881 in Healthy Subjects.
- Study of PTG-300 in Non-Transfusion Dependent and Transfusion-Dependent Beta-Thalassemia Subjects With Chronic Anemia
- Study to Evaluate the Long-term Safety of Rusfertide (PTG-300) in Subjects With Polycythemia Vera